These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1802925)

  • 21. Vasoactive intestinal peptide is a hypothalamic prolactin-releasing neuropeptide in the turkey (Meleagris gallopavo).
    el Halawani ME; Silsby JL; Mauro LJ
    Gen Comp Endocrinol; 1990 Apr; 78(1):66-73. PubMed ID: 2158920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo antisense antagonism of vasoactive intestinal peptide in the suprachiasmatic nuclei causes aging-like changes in the estradiol-induced luteinizing hormone and prolactin surges.
    Harney JP; Scarbrough K; Rosewell KL; Wise PM
    Endocrinology; 1996 Sep; 137(9):3696-701. PubMed ID: 8756535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of vasoactive intestinal peptide in the control of prolactin-induced turkey incubation behavior. II. Chronic infusion of vasoactive intestinal peptide.
    Pitts GR; Youngren OM; Silsby JL; Rozenboim I; Chaiseha Y; Phillips RE; Foster DN; el Halawani ME
    Biol Reprod; 1994 Jun; 50(6):1350-6. PubMed ID: 8080923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ovine prolactin administration on hypothalamic vasoactive intestinal peptide (VIP), gonadotropin releasing hormone I and II content, and anterior pituitary VIP receptors in laying turkey hens.
    Rozenboim I; Tabibzadeh C; Silsby JL; el Halawani ME
    Biol Reprod; 1993 Jun; 48(6):1246-50. PubMed ID: 8391330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen regulates the gene expression of vasoactive intestinal peptide in the anterior pituitary.
    Lam KS; Srivastava G; Lechan RM; Lee T; Reichlin S
    Neuroendocrinology; 1990 Nov; 52(5):417-21. PubMed ID: 2126350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
    Gómez O; Balsa JA
    Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
    Murai I; Reichlin S; Ben-Jonathan N
    Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autocrine control of prolactin secretion by vasoactive intestinal peptide.
    Nagy G; Mulchahey JJ; Neill JD
    Endocrinology; 1988 Jan; 122(1):364-6. PubMed ID: 3335213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterior pituitary vasoactive intestinal peptide mRNA is colocalised with prolactin mRNA in hyperoestrogenised rats.
    Chew LJ; Seah V; Murphy D; Carter D
    J Mol Endocrinol; 1996 Jun; 16(3):211-20. PubMed ID: 8782079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat.
    Ohta H; Kato Y; Shimatsu A; Tojo K; Kabayama Y; Inoue T; Yanaihara N; Imura H
    Eur J Pharmacol; 1985 Mar; 109(3):409-12. PubMed ID: 3872804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro stimulation of prolactin release by vasoactive intestinal peptide.
    Samson WK; Said SI; Snyder G; McCann SM
    Peptides; 1980; 1(4):325-32. PubMed ID: 7301635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
    Kang SW; Youngren OM; El Halawani ME
    Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasoactive intestinal peptide in the anterior pituitary is increased in hypothyroidism.
    Lam KS; Lechan RM; Minamitani N; Segerson TP; Reichlin S
    Endocrinology; 1989 Feb; 124(2):1077-84. PubMed ID: 2912685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thyroid status on the prolactin-releasing action of vasoactive intestinal peptide in humans: comparison with the action of thyrotropin-releasing hormone.
    Watanobe H; Sasaki S
    Neuroendocrinology; 1995 Feb; 61(2):207-12. PubMed ID: 7753340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland.
    Segerson TP; Lam KS; Cacicedo L; Minamitani N; Fink JS; Lechan RM; Reichlin S
    Endocrinology; 1989 Oct; 125(4):2221-3. PubMed ID: 2791988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
    Shah GV; Shyr SW; Grosvenor CE; Crowley WR
    Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of passive immunization against vasoactive intestinal peptide on serum prolactin and LH levels.
    Lasaga M; Debeljuk L; Afione S; Aleman IT; Duvilanski B
    Neuroendocrinology; 1989 Jun; 49(6):574-9. PubMed ID: 2770978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.